Afolabi O Adegbite is a Bronx, New York based nurse practitioner. Active license number of Afolabi O Adegbite is F404932-01 for Psych/Mental Health in New York. His current practice location is 402 Screvin Ave, Bronx. Patients can reach him at 347-279-0765 and his NPI number (Unique professional ID assigned by NPPES) is 1558853408. Afolabi O Adegbite has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Afolabi O Adegbite speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1558853408
NPI Enumeration Date:
05 Jun, 2018
NPI Last Update On:
04 Aug, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Afolabi O Adegbite are as mentioned below.
License Number
Specialization
State
Status
F404932-01
Psych/Mental Health
New York
Primary
735954
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Afolabi O Adegbite 402 Screvin Ave, Bronx, New York
Zip:
10473-1810
Phone Number:
347-279-0765
Patients can reach Afolabi O Adegbite at 402 Screvin Ave, Bronx, New York or can call to book an appointment on 347-279-0765.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.